Your browser is no longer supported. Please, upgrade your browser.
MRK Merck & Co., Inc. weekly Stock Chart
MRK [NYSE]
Merck & Co., Inc.
IndexDJIA S&P500 P/E19.30 EPS (ttm)3.98 Insider Own0.10% Shs Outstand2.53B Perf Week-2.60%
Market Cap193.57B Forward P/E12.63 EPS next Y6.07 Insider Trans-4.25% Shs Float2.52B Perf Month-6.16%
Income10.20B PEG3.22 EPS next Q1.05 Inst Own77.70% Short Float0.58% Perf Quarter-6.98%
Sales48.08B P/S4.03 EPS this Y58.90% Inst Trans0.23% Short Ratio1.38 Perf Half Y-14.15%
Book/sh10.35 P/B7.41 EPS next Y14.61% ROA12.10% Target Price93.00 Perf Year-5.27%
Cash/sh2.95 P/C26.05 EPS next 5Y6.00% ROE38.10% 52W Range65.25 - 92.64 Perf YTD-15.63%
Dividend2.44 P/FCF61.86 EPS past 5Y-1.10% ROI19.20% 52W High-17.17% Beta0.49
Dividend %3.18% Quick Ratio0.90 Sales past 5Y2.10% Gross Margin72.20% 52W Low17.59% ATR1.72
Employees71000 Current Ratio1.10 Sales Q/Q11.50% Oper. Margin25.50% RSI (14)46.45 Volatility1.80% 2.26%
OptionableYes Debt/Eq1.07 EPS Q/Q10.30% Profit Margin21.10% Rel Volume0.46 Prev Close76.69
ShortableYes LT Debt/Eq0.83 EarningsJul 31 BMO Payout58.30% Avg Volume10.55M Price76.73
Recom2.00 SMA20-0.34% SMA50-1.86% SMA200-6.84% Volume4,925,037 Change0.05%
Jun-12-20Downgrade Wolfe Research Outperform → Peer Perform
Feb-27-20Initiated Barclays Overweight $93
Jan-07-20Initiated RBC Capital Mkts Sector Perform $99
Oct-17-19Resumed BofA/Merrill Neutral $90
Aug-16-19Initiated SVB Leerink Outperform
Jul-03-19Initiated Mizuho Buy $97
May-28-19Initiated Goldman Neutral
May-13-19Upgrade Atlantic Equities Neutral → Overweight
Oct-16-18Reiterated Citigroup Buy $70 → $79
Oct-09-18Resumed Guggenheim Buy
Apr-23-18Upgrade Goldman Neutral → Buy
Apr-17-18Upgrade Morgan Stanley Equal-Weight → Overweight
Apr-05-18Upgrade Barclays Equal Weight → Overweight $62 → $64
Mar-12-18Upgrade Leerink Partners Mkt Perform → Outperform
Feb-14-18Reiterated Leerink Partners Mkt Perform $67 → $66
Feb-07-18Reiterated Morgan Stanley Equal-Weight $60 → $63
Jan-16-18Upgrade SunTrust Hold → Buy
Nov-28-17Resumed BofA/Merrill Buy $64
Nov-24-17Reiterated Deutsche Bank Hold $62 → $59
Oct-31-17Upgrade Jefferies Underperform → Hold
Jul-10-20 10:21AM  
Jul-09-20 04:30PM  
02:10PM  
11:44AM  
08:53AM  
08:45AM  
08:40AM  
08:13AM  
07:00AM  
06:45AM  
Jul-08-20 04:30PM  
01:21PM  
12:59PM  
11:30AM  
11:29AM  
07:38AM  
07:01AM  
06:55AM  
06:45AM  
02:24AM  
02:15AM  
Jul-07-20 05:50PM  
06:00AM  
Jul-06-20 06:45AM  
Jul-03-20 09:24AM  
Jul-02-20 05:38PM  
03:23PM  
01:02PM  
12:10PM  
08:21AM  
02:00AM  
Jul-01-20 04:30PM  
03:24PM  
10:45AM  
06:45AM  
Jun-30-20 11:45AM  
10:34AM  
07:41AM  
06:40AM  
Jun-29-20 04:20PM  
09:36AM  
07:47AM  
Jun-26-20 09:22PM  
Jun-25-20 03:26PM  
08:26AM  
Jun-24-20 05:29PM  
06:45AM  
Jun-23-20 05:50PM  
11:31AM  
10:45AM  
09:45AM  
07:23AM  
Jun-22-20 12:52PM  
09:34AM  
06:45AM  
06:30AM  
Jun-19-20 12:02PM  
08:29AM  
Jun-18-20 11:35AM  
10:45AM  
Jun-17-20 05:45PM  
04:30PM  
02:32PM  
09:52AM  
09:23AM  
08:41AM  
07:30AM  
06:45AM  
06:30AM  
Jun-16-20 07:00PM  
03:07PM  
02:06PM  
01:15PM  
01:05PM  
01:01PM  
12:43PM  
12:01PM  
10:36AM  
Jun-15-20 05:00PM  
12:46PM  
11:46AM  
10:46AM  
10:45AM  
09:36AM  
08:00AM  
01:48AM  
Jun-14-20 01:52PM  
Jun-13-20 08:21AM  
06:55AM  
Jun-12-20 06:40PM  
02:12PM  
01:48PM  
10:04AM  
08:54AM  
Jun-11-20 11:34PM  
11:37AM  
Jun-10-20 04:53PM  
09:09AM  
05:02AM  
Jun-09-20 04:44PM  
Merck & Co., Inc. provides healthcare solutions worldwide. The company offers therapeutic and preventive agents for cardiovascular, type 2 diabetes, chronic hepatitis C virus, HIV-1 infection, intra-abdominal, fungal infection, insomnia, and inflammatory diseases; neuromuscular blocking agents; cholesterol modifying medicines; and anti-bacterial and vaginal contraceptive products. It provides products to prevent chemotherapy-induced and post-operative nausea and vomiting; treat non-small-cell lung, ovarian and breast, esophageal, thyroid, cervical, and brain cancers; and prevent diseases caused by human papillomavirus, as well as vaccines for measles, mumps, rubella, varicella, shingles, rotavirus gastroenteritis, and pneumococcal diseases. In addition, the company offers drugs for hepatocellular and merkel cell carcinoma; antibiotic and anti-inflammatory drugs for infectious and respiratory diseases, fertility disorders, and pneumonia in cattle, bovine, and swine; vaccines for poultry; parasiticides for sea lice in salmon; and antibiotics and vaccines for fish. Further, it provides companion animal products; diabetes mellitus treatment and anthelmintic products for dogs and cats; products to treat fleas, ticks, mosquitoes, and sandflies; horse fertility management products for swine; and dog, cat, and horse vaccines. Additionally, the company offers services and solutions that focus on engagement, clinical, and health analytics. Merck & Co., Inc. has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Almac Discovery Ltd.; Skyhawk Therapeutics, Inc.; Ridgeback Biotherapeutics; Shanghai Junshi Biosciences Co., Ltd.; and FUJIFILM Corporation. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers; and physicians and physician distributors, veterinarians, and animal producers. The company was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BRUN LESLIE ADirectorMay 07Option Exercise0.005,00006,948May 07 04:48 PM
WEEKS WENDELL PDirectorMay 07Option Exercise0.005,00005,100May 07 04:50 PM
BRUN LESLIE ADirectorMay 07Sale75.465,000377,3001,948May 07 04:48 PM
WEEKS WENDELL PDirectorMay 07Sale76.025,000380,104100May 07 04:50 PM
Nally MichaelEVP, Chief Marketing OfficerMay 05Option Exercise76.862,345180,23712,054May 06 05:14 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 05Option Exercise76.863,283252,33129,401May 06 05:15 PM
Fleming MichaelSVP Chief Ethics & Com OfficerMay 05Option Exercise76.861,29099,1497,304May 06 05:16 PM
Clyburn FrankEVP, Chief Commercial OfficerMay 05Option Exercise76.863,752288,37982,611May 06 05:17 PM
Clyburn FrankEVP, Chief Commercial OfficerMay 04Option Exercise77.671,904147,88479,797May 06 05:17 PM
Fleming MichaelSVP Chief Ethics & Com OfficerMay 04Option Exercise77.6769253,7486,252May 06 05:16 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 04Option Exercise77.671,21294,13626,715May 06 05:15 PM
Zachary JenniferEVP, General CounselMay 04Option Exercise77.675,772448,3119,489May 06 05:13 PM
Nally MichaelEVP, Chief Marketing OfficerMay 04Option Exercise77.671,298100,81610,274May 06 05:14 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 03Option Exercise77.6787567,96125,934May 05 04:48 PM
Fleming MichaelSVP Chief Ethics & Com OfficerMay 03Option Exercise77.671,541119,6896,089May 05 04:42 PM
Gerberding Julie L.EVP Strat Comm, GI Pub PolicyJan 13Option Exercise0.0082,5480139,111Jan 15 05:15 PM
Gerberding Julie L.EVP Strat Comm, GI Pub PolicyJan 13Sale89.34102,0739,118,86537,038Jan 15 05:15 PM
Nally MichaelEVP, Chief Marketing OfficerOct 30Option Exercise0.002,28706,196Nov 01 05:07 PM
MIZELL STEVENEVP, Chief HR OfficerOct 30Option Exercise0.004,57404,574Nov 01 05:07 PM
Clyburn FrankEVP, Chief Commercial OfficerOct 30Option Exercise0.002,287073,032Nov 01 05:06 PM
Scholefield James HEVP,Chief Info&Digital OfficerOct 30Option Exercise0.0011,436011,436Nov 01 05:04 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthAug 09Option Exercise0.006,427077,951Aug 12 05:13 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthAug 09Sale85.096,427546,85071,524Aug 12 05:13 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthAug 08Option Exercise0.0031,6990103,223Aug 12 05:13 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthAug 08Sale85.0131,6992,694,78971,524Aug 12 05:13 PM